Clindamycin Injection 300mg/2mL

Clindamycin Injection 300mg | Lincosamide Antibacterial Injection
  • Dosage: Clindamycin 300mg
  • Volume:  2 ml Ampoule
  • Packaging: 2 ml ampoule * 10/tray/box*300 carton
  • Shelf Life: 36 months 

Click to add this item to cart.

Product Description

Product NameClindamycin Injection
Specification300mg/2mL (150mg/mL)
Dosage FormSterile Solution for Injection / Infusion
Active IngredientClindamycin (as Clindamycin Phosphate)
Pharmacological ClassLincosamide Antibacterial Agent
Route of AdministrationIntravenous infusion (after dilution), or deep intramuscular injection. NOT for direct intravenous bolus injection.
Packaging2mL amber glass ampoule
StorageStore below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use.
Shelf Life36 months (unopened)

Product Overview

Clindamycin Injection 300mg/2mL is a sterile, aqueous solution of clindamycin phosphate intended for parenteral administration. Each 2mL ampoule contains clindamycin phosphate equivalent to 300mg of clindamycin, providing a concentration of 150mg/mL. Clindamycin is a lincosamide antibacterial agent with activity against a wide range of Gram-positive organisms and anaerobic bacteria.

Clindamycin Injection 300mg/2mL: What the Published Guidance Says

A broad portfolio spanning the WHO Access and Watch groups, supplied with the documentation that stewardship programmes and national tenders require.

Clindamycin Injection 300mg/2mL is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Antibacterials range overview.

  • Access group — the empirical workhorses The WHO AWaRe classification places amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole, chloramphenicol and doxycycline in the Access group. These are the medicines expected to be available in every functioning health system. WHO AWaRe (Access, Watch, Reserve) classification of antibiotics
  • AWaRe is the framework buyers and stewards now work to WHO's AWaRe classification divides antibiotics into Access, Watch and Reserve. Access agents are described as those that should be widely available, affordable and quality-assured to improve access and promote appropriate use. Watch agents carry higher resistance potential and should be prioritised as targets of stewardship programmes and monitoring. WHO Antibiotics Portal — AWaRe
  • WHO's own indication mapping is public — we align to it The WHO Antibiotics Portal lists amoxicillin as first choice for community-acquired pneumonia (mild to moderate), acute otitis media, acute sinusitis, acute pharyngitis and uncomplicated acute malnutrition in children; amoxicillin + clavulanic acid as first choice for severe community-acquired pneumonia in children, hospital-acquired pneumonia, cystitis and cellulitis; and ceftriaxone as first choice for severe acute pyelonephritis. WHO Antibiotics Portal — AWaRe

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Clindamycin Injection 300mg/2mL. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

Clindamycin Injection 300mg/2mL — Supply Parameters

Product NameClindamycin Injection
Specification300mg/2mL (150mg/mL)
Dosage FormSterile Solution for Injection / Infusion
Active IngredientClindamycin (as Clindamycin Phosphate)
Pharmacological ClassLincosamide Antibacterial Agent
Route of AdministrationIntravenous infusion (after dilution), or deep intramuscular injection. NOT for direct intravenous bolus injection.
StorageStore below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use.
Therapeutic groupAntibacterials — Antibacterials
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Levofloxacin Lactate Injection 100ml:300mg, Ciprofloxacin Lactate Injection 200mg/100mL, Amoxicillin Powder for Injection 1g, Netilmicin Injection 100mg/2ml, Metronidazole Injection 5mL:25mg, Gentamicin Injection 2mL:80mg, Ceftriaxone Powder for Injection 1g, Metronidazole Injection 500mg 100ml.

Quality Control, Pharmacopoeial Standards & Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of Clindamycin Injection 300mg/2mL is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

A typical release panel for this presentation covers:

  • Testing for description and identification
  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)
  • Testing for uniformity of dosage units
  • Testing for water content and pH where applicable

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packaging, Labelling & Export

  • Pack size: 2mL amber glass ampoule. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use..
  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Registration, Dossier & Tender Support

Documents for Clindamycin Injection 300mg/2mL are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
  • Batch manufacturing and packaging records released for inspection on request during supplier audits.
  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.

The context for Clindamycin Injection 300mg/2mL is its place among antibacterials classified in the WHO AWaRe framework. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.

Frequently Asked Questions

What pack size is available for Clindamycin Injection 300mg/2mL?

This presentation is normally supplied as 2mL amber glass ampoule. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.

What documentation comes with a shipment of Clindamycin Injection 300mg/2mL?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.

Does the batch documentation for Clindamycin Injection 300mg/2mL support a registration filing?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Which of your antibiotics are in the WHO Access group?

Amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole and chloramphenicol are classified in the Access group under the WHO AWaRe classification.

Can you supply sterile injectable antibiotics with endotoxin data?

Yes. Injectable products are supplied with sterility and bacterial endotoxin results included on the batch certificate of analysis, alongside assay and related-substances data.

Related Antibacterials Products

Browse the full Antibacterials range; all Injectables; the complete product catalogue.

Request a Quotation for Clindamycin Injection 300mg/2mL

For tenders and programme supply, send the line item, pack size, quantity and destination for Clindamycin Injection 300mg/2mL 300mg/2mL. We return a quotation with lead time, documentation list and sample availability in one response.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products